294 related articles for article (PubMed ID: 35059996)
1. New Developments in Gastric Neuroendocrine Neoplasms.
Exarchou K; Stephens NA; Moore AR; Howes NR; Pritchard DM
Curr Oncol Rep; 2022 Jan; 24(1):77-88. PubMed ID: 35059996
[TBL] [Abstract][Full Text] [Related]
2. Gastric neuroendocrine neoplasms: A review.
Köseoğlu H; Duzenli T; Sezikli M
World J Clin Cases; 2021 Sep; 9(27):7973-7985. PubMed ID: 34621854
[TBL] [Abstract][Full Text] [Related]
3. Gastric and duodenal neuroendocrine tumours.
O'Toole D; Delle Fave G; Jensen RT
Best Pract Res Clin Gastroenterol; 2012 Dec; 26(6):719-35. PubMed ID: 23582915
[TBL] [Abstract][Full Text] [Related]
4. Gastric Carcinoids.
Grozinsky-Glasberg S; Alexandraki KI; Angelousi A; Chatzellis E; Sougioultzis S; Kaltsas G
Endocrinol Metab Clin North Am; 2018 Sep; 47(3):645-660. PubMed ID: 30098721
[TBL] [Abstract][Full Text] [Related]
5. [Consensus and controversy on subtype classification of gastric neuroendocrine neoplasms].
Tan H
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):977-981. PubMed ID: 28900986
[TBL] [Abstract][Full Text] [Related]
6. Endoscopic surveillance alone is feasible and safe in type I gastric neuroendocrine neoplasms less than 10 mm in diameter.
Exarchou K; Hu H; Stephens NA; Moore AR; Kelly M; Lamarca A; Mansoor W; Hubner R; McNamara MG; Smart H; Howes NR; Valle JW; Pritchard DM
Endocrine; 2022 Oct; 78(1):186-196. PubMed ID: 35895180
[TBL] [Abstract][Full Text] [Related]
7. [Consensus and controversy of endoscopic diagnosis and treatment of gastroenteropancreatic neuroendocrine tumors].
Chen H; Chen Y
Zhonghua Wei Chang Wai Ke Za Zhi; 2017 Sep; 20(9):982-986. PubMed ID: 28900987
[TBL] [Abstract][Full Text] [Related]
8. Gastroenteropancreatic neuroendocrine neoplasms: genes, therapies and models.
Kawasaki K; Fujii M; Sato T
Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29590641
[TBL] [Abstract][Full Text] [Related]
9. Gastric neuroendocrine neoplasms and precursor lesions: Case reports and literature review.
Boeriu A; Dobru D; Fofiu C; Brusnic O; Onişor D; Mocan S
Medicine (Baltimore); 2022 Jan; 101(2):e28550. PubMed ID: 35029217
[TBL] [Abstract][Full Text] [Related]
10. Gastric neuroendocrine neoplasms.
Lamberti G; Panzuto F; Pavel M; O'Toole D; Ambrosini V; Falconi M; Garcia-Carbonero R; Riechelmann RP; Rindi G; Campana D
Nat Rev Dis Primers; 2024 Apr; 10(1):25. PubMed ID: 38605021
[TBL] [Abstract][Full Text] [Related]
11. Review article: the investigation and management of gastric neuroendocrine tumours.
Basuroy R; Srirajaskanthan R; Prachalias A; Quaglia A; Ramage JK
Aliment Pharmacol Ther; 2014 May; 39(10):1071-84. PubMed ID: 24628514
[TBL] [Abstract][Full Text] [Related]
12. Current understanding of pathogenetic mechanisms in neuroendocrine neoplasms.
Modica R; Liccardi A; Minotta R; Cannavale G; Benevento E; Colao A
Expert Rev Endocrinol Metab; 2024; 19(1):49-61. PubMed ID: 37936421
[TBL] [Abstract][Full Text] [Related]
13. Diagnosis and treatment of gastric neuroendocrine tumours.
Plöckinger U
Wien Klin Wochenschr; 2007; 119(19-20):570-2. PubMed ID: 17985089
[TBL] [Abstract][Full Text] [Related]
14. Multiple endocrine neoplasia type 1 (MEN-1) and neuroendocrine neoplasms (NENs).
Effraimidis G; Knigge U; Rossing M; Oturai P; Rasmussen ÅK; Feldt-Rasmussen U
Semin Cancer Biol; 2022 Feb; 79():141-162. PubMed ID: 33905872
[TBL] [Abstract][Full Text] [Related]
15. Clinical management of patients with gastric neuroendocrine neoplasms associated with chronic atrophic gastritis: a retrospective, multicentre study.
Campana D; Ravizza D; Ferolla P; Faggiano A; Grimaldi F; Albertelli M; Berretti D; Castellani D; Cacciari G; Fazio N; Colao A; Ferone D; Tomassetti P
Endocrine; 2016 Jan; 51(1):131-9. PubMed ID: 25814125
[TBL] [Abstract][Full Text] [Related]
16. Gastro-entero-pancreatic neuroendocrine neoplasia: The rules for non-operative management.
Panzuto F; Massironi S; Partelli S; Campana D; Rinzivillo M; Invernizzi P; Andreasi V; Lamberti G; Falconi M
Surg Oncol; 2020 Dec; 35():141-148. PubMed ID: 32877883
[TBL] [Abstract][Full Text] [Related]
17. Appendiceal neuroendocrine neoplasms: diagnosis and management.
Alexandraki KI; Kaltsas GA; Grozinsky-Glasberg S; Chatzellis E; Grossman AB
Endocr Relat Cancer; 2016 Jan; 23(1):R27-41. PubMed ID: 26483424
[TBL] [Abstract][Full Text] [Related]
18. Morphological, molecular, and prognostic aspects of gastric endocrine tumors.
Solcia E; Rindi G; Larosa S; Capella C
Microsc Res Tech; 2000 Mar; 48(6):339-48. PubMed ID: 10738315
[TBL] [Abstract][Full Text] [Related]
19. Management of gastric and duodenal neuroendocrine tumors.
Sato Y; Hashimoto S; Mizuno K; Takeuchi M; Terai S
World J Gastroenterol; 2016 Aug; 22(30):6817-28. PubMed ID: 27570419
[TBL] [Abstract][Full Text] [Related]
20. Circulating miRNA-202-3p is a potential novel biomarker for diagnosis of type 1 gastric neuroendocrine neoplasms.
Dou D; Li XK; Xia QS; Chen YY; Li YL; Wang C; Qi ZR; Tan HY
BMC Gastroenterol; 2021 Apr; 21(1):188. PubMed ID: 33892648
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
